Clinical outcomes and factors involved in the local control of proton beam therapy for oligometastatic liver tumors in patients with colorectal cancer

[1]  C. Hsueh,et al.  Proton stereotactic body radiation therapy for liver metastases-results of 5-year experience for 81 hepatic lesions. , 2021, Journal of gastrointestinal oncology.

[2]  T. Ohno,et al.  Carbon-ion Radiotherapy for Oligometastatic Colorectal Cancer in the Liver or Lung , 2021, AntiCancer Research.

[3]  I. Seto,et al.  The effectiveness of proton beam therapy for liver metastatic recurrence in gastric cancer patients. , 2020, Japanese journal of clinical oncology.

[4]  S. Barni,et al.  Stereotactic body radiotherapy for colorectal cancer liver metastases: A systematic review. , 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  L. Dawson,et al.  Long-Term Outcomes of Phase 1 and 2 Studies of SBRT for Hepatic Colorectal Metastases. , 2017, International journal of radiation oncology, biology, physics.

[6]  H. Ishikawa,et al.  Follow-up study of liver metastasis from breast cancer treated by proton beam therapy. , 2017, Molecular and clinical oncology.

[7]  H. Shiomi,et al.  Effect of primary tumor location and tumor size on the response to radiotherapy for liver metastases from colorectal cancer. , 2017, Oncology letters.

[8]  B. Heijmen,et al.  Institutional experience in the treatment of colorectal liver metastases with stereotactic body radiation therapy. , 2017, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

[9]  H. Ishikawa,et al.  Proton beam therapy for liver metastases from gastric cancer , 2016, Journal of radiation research.

[10]  S. Eschrich,et al.  Radiosensitivity Differences Between Liver Metastases Based on Primary Histology Suggest Implications for Clinical Outcomes After Stereotactic Body Radiation Therapy. , 2016, International journal of radiation oncology, biology, physics.

[11]  Erich P Huang,et al.  RECIST 1.1-Update and clarification: From the RECIST committee. , 2016, European journal of cancer.

[12]  H. Cárdenes,et al.  Long-term safety and efficacy of stereotactic body radiation therapy for hepatic oligometastases. , 2016, Practical radiation oncology.

[13]  H. Ishikawa,et al.  Proton beam therapy for metastatic liver tumors. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  M. Scorsetti,et al.  Final results of a phase II trial for stereotactic body radiation therapy for patients with inoperable liver metastases from colorectal cancer , 2015, Journal of Cancer Research and Clinical Oncology.

[15]  J. Balter,et al.  Stereotactic body radiation therapy for primary and metastatic liver tumors. , 2013, Translational oncology.

[16]  Ralf-Thorsten Hoffmann,et al.  Percutaneous radiofrequency ablation (RFA) or robotic radiosurgery (RRS) for salvage treatment of colorectal liver metastases , 2013, Acta oncologica.

[17]  Y. Kanda,et al.  Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.

[18]  A. Koong,et al.  Stereotactic Body Radiotherapy for Colorectal Liver Metastases: A Pooled Analysis , 2010 .

[19]  P. Levendag,et al.  Stereotactic body radiation therapy for colorectal liver metastases , 2010, The British journal of surgery.

[20]  Mi-Sook Kim,et al.  Three-fraction stereotactic body radiation therapy for isolated liver recurrence from colorectal cancer. , 2009, Tumori.

[21]  J. Petersen,et al.  Phase II study on stereotactic body radiotherapy of colorectal metastases , 2006, Acta oncologica.

[22]  Daniel W. Miller,et al.  Methodologies and tools for proton beam design for lung tumors. , 2001, International journal of radiation oncology, biology, physics.